Home > News > Nanogen, Novavax Shares Fail to Provide Payoffs
August 9th, 2006
Nanogen, Novavax Shares Fail to Provide Payoffs
Abstract:
Nanogen Inc., one of 25 companies in the Merrill Lynch Nanotech Index that manipulate particles smaller than 100 nanometers, has slumped since May. Novavax Inc., a vaccine developer in Malvern, Pennsylvania, has declined 44 percent. Reno, Nevada-based Altair Nanotechnologies Inc., which makes materials used in paints and fuel cells, has fallen 22 percent. BioSante Pharmaceuticals Inc., based in Lincolnshire, Illinois, has tumbled 51 percent, the biggest drop in the Merrill index.
Source:
bloomberg.com
Bookmark:
| Related Links |
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||